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OBSERVATIONS ON THE REACTION OF CHRONIC INFLAMMATORY
DERMATOSES AND OF NORMAL SKIN TO VARIED CONCENTRA-
TIONS OF THORIUM X*
OWEN S. HENDREN, M.D. AND HERMANN PINKUS, M.D.
Thorium X, a naturally occurring source of alpha rays, which had been used
in the topical treatment of skin diseases for more than forty years, became com-
mercially available in the United States only recently. Numerous articles on the
action and medical uses of this substance have been published in European (1)
and British journals (2), and lately a number of clinical and experimental studies
were reported in this country (3). While one of us (H. P.) had used Thorium X
in private practice as an adjunct to other types of therapy for a number of years
(3b), it was the plan of the present investigation to study the feasibility of using
thorium X as the sole therapeutic agent in clinic patients suffering from common
chronic inflammatory dermatoses such as psoriasis or lichen simplex chronicus.
It was endeavored to establish the smallest effective concentration and also to
investigate the reaction of normal skin to various concentrations of thorium X.
PHYSICAL AND CHEMICAL DIFFERENCES BETWEEN THORIUM X, RADIUM, AND RADON
Thorium X is a naturally occurring disintegration product in the thorium series
of radioactive elements (4). Being an isotope of radium it is an alkaline earth
metal and forms soluble salts which can be used in aqueous and alcoholic solu-
tion, or can be incorporated in ointments. It is important to realize that the
radiation and decay of thorium X are fundamentally different from radium.
Thorium X has a half life of 3.64 days, and all of its breakdown products are
even more short lived until thorium D (thorium lead) is formed which is stable.
Thorium X emits alpha rays and transforms into thoron which is an inert gas
with a half life of only 54.6 seconds. Thoron also emits alpha rays and forms
Thorium A which together with the disintegration products thorium B, C, C',
and C" is known as the insoluble precipitate because of the fact that in an
alkaline medium these elements are precipitated out quantitatively, while
thorium X remains in solution. Only thorium B, C, and C" emit beta and
gamma rays while thorium A, C, and C' emit alpha rays either wholly or in
part. According to the manufacturer* 91.4% of the total calculated energy
emitted by a thorium X preparation is contributed by alpha rays.
On superficial examination it would appear that the properties of thorium X
are quite similar to radon which also has been recommended for topical applica-
* From the Department of Dermatology (Loren W. Shaffer, M.D., Chairman) and the
Department of Pathology (Osborne A. Brines, M.D., Chairman) of the Detroit Receiving
Hospital and Wayne University College of Medicine.
Received for publication September 4, 1953.
* The Thorium X used in this study was furnished by the manufacturer, Fleischman,
Burd and Co., Inc. of New York City, through the courtesy of Mr. Alex Meshbane. Mr.
Meshbane also supplied some of the physical and chemical data on thorium X.
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TABLE 1
THORItTh X RADON
Chemical properties Alkaline earth metal forming
soluble salts
Inert diffusible gas
Half life 3.64 days 3.82 days
Longest half life of any disinte-
gration product Thorium B 10.6 hours Radium D 22 years
Half life of gaseous phase Thoron 54.6 seconds Radon 3.82 days
Percentage of energy emitted as
Alpha rays 91.4% 76%
Beta rays 4.1% 17%
Gamma rays 4.5% 8%
tion in ointment form. There are, however, some important differences which
are listed in Table 1.
Thorium X is easier to handle and need not be covered with an occlusive
dressing. It can be painted on in solution where greasy ointments are contra-
indicated. A higher percentage of the radiation is alpha rays. Practically all
radioactivity has disappeared in about 13 days. There is relatively little chance
for an inert gas to diffuse into the deeper tissues. It has been shown by Lange
and Evans (5) that when radon was applied to normal skin in the usual way
under an occlusive dressing, 4.5 % could be recovered in the exhaled air within
23 hours. This means, of course, that a considerable percentage of radon diffuses
into the body from the skin surface. Witten and associates (3h) have shown
recently by means of autoradiograms that most of the thorium X which was
painted on the skin remained on the skin surface, smaller amounts were de-
tected in the epidermis and also in the epithelial adenexa but almost none in
the connective tissue of the corium.
MATERIAL AND METHODS
The thorium X used in this study was furnished in the form of propylalcoholic
solution standardized to contain 1000 electrostatic units of 150 Mc per ml. at the
time of use. For comparative studies some of this material was diluted after ar-
rival with alcohol to make 75 c, 37.5 Mc, and 15 c concentrations per ml. In
order to avoid cumbersome repetitions, these solutions will be referred to as
thorium X(150), thorium X(75) etc. in the text. The radioactive solutions were
painted on the skin lesions with a cotton tipped applicator by one of us (0. H.)
and allowed to dry. No dressing was applied. The patients were instructed not to
wash off or otherwise remove the -invisible- deposit for 48 hours. Only occa-
sionally was any other medication used and then only a bland soothing oint-
ment. Application of thorium X were repeated at weekly intervals.
CLINICAL DATA
This report includes a total of 41 patients, 27 negroes, 12 whites, 1 Mexican,
and 1 Japanese. There were three cases of stasis dermatitis of the legs, four of
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atopic dermatitis, twenty three of circumscribed lichen simplex chronicus, and
one case each of contact dermatitis, seborrheic dermatitis, lichen sclerosus et
atrophicus, pruritus ani et scroti, -id type of toxic dermatitis, and eczema of the
nipple. There are also reported three cases of psoriasis and two of lichen planus.
The diagnosis was made from the clinical appearance and history and was con-
firmed by biopsy in several instances. The data on each patient are given in
Table 2.
It is extremely difficult to summarize and interpret the results in this series
in a few words, due to the multiplicity of diagnoses, and the variety of concen-
trations of thorium X used for purposes of comparison. These factors will be
discussed later on. Results were listed as good in twenty two cases, good with
later recurrences in five. There was considerable improvement in eight cases.
The effects were listed as poor in three and as none in three other instances.
The failures comprised one of two cases of lichen planus, one case of lichen
sclerosus et atrophicus, and one case of an -id type of toxic dermatitis the cause
of which was not established. The three poor results were in one of three cases
of chronic stasis dermatitis, one of the twenty three cases of lichen simplex
chronicus, and one case of long standing exudative neurodermatitis of the nipple.
The favorable results, either complete resolution of the lesions with or without
later recurrence, or great improvement, were obtained in twenty two of the
twenty three cases of lichen simplex chronicus, in all three cases of psoriasis,
one each of seborrheic dermatitis, contact dermatitis, and pruritus ani, one of
two lichen planus, and two of three cases of stasis dermatitis.
The number of applications ranged from three to a maximum of thirty four
in one case. Counting individual areas treated, eighteen received from three to
five applications, twenty areas were treated from six to ten times, nine areas
eleven to fifteen times, five areas sixteen to twenty times, and five areas more
than twenty times. It was mentioned before that concentrations applied ranged
from 15 c/ml to 150 c/ml.
Comparison of Clinical Effectiveness of Varied Concentrations
Most authors have employed concentrations of 150 c per ml when they used
thorium X for topical application, some have recommended 300 jc/ml. F. Pinkus
(6) seems to be the only one who claimed to have achieved persistently good re-
sults with much lower concentrations, 15—37.5 jic/ml. His reason for employing
smaller doses was the fact that 150 c and more will produce, on normal skin,
erythema and often considerable pigmentation which he wished to avoid. It
must be realized in this respect that concentration of the solution is not the
only factor in determining the local effect. Much depends on whether the satu-
rated cotton swab is rolled lightly over a large area, or if the same amount of
solution is used to "soak" a small area. The degree to which scales are removed
from a lesion prior to application makes a difference. Finally, one may apply an
impervious coat of laquer or collodion over the thorium X in order to enhance
its effectiveness. Thus the technical details used by various observers may in-
fluence their results. It was considered one purpose of the present study to treat
similar lesions in the same patient with different concentrations of thorium X.
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TABLE 2
CASE SEX AGE COLOR DIAGNOSIS C PEE CC. NO.OP RESULTS
1 M 62 W Stasis dermatitis, lower 150 3 Improved
legs2 M 53 C Stasis dermatitis, lower 37.5 6 Good but re-
legs 75 12 curred3 M 64 W Stasis dermatitis, lower 75 28 Poor
legs4 F 17 C Atopic dermatitis neck & 75 7 Good, recurred
anticubital spaces after 15
months5 F 12 C Atopic dermatitis neck & 75 11 Good
anticubital spaces6 F 7 C Atopic dermatitis, neck & 75 4 Good
anticubital spaces7 M 36 W Atopic dermatitis, anticu- 37.5 14 Improved
bital spaces, chest &
shoulders
8 M 44 C Lichen planus 75 6 None9 F 37 C Lichen planus 150 3 Good
150 18 Good10 F 36 C Lichen simplex chronicus Rt. 75 5 Good
sides & back of neck Lt. 15 5 Improved11 M 53 C Lichen simplex chronicus 37.5 8 Good
lower legs 75 3
12 M 51 C Lichen simplex chronicus 37.5 4 Good
lower rt. shin, scrotum 75 3
13 M 32 C Lichen simplex chronicus 75 5 Good
outer surface It. lower
leg14 F 48 C Lichen simplex chronicus 75 6 Good
lt. side neck, extensor
surface rt. lower arm
15 M 49 W Lichen simplex chronicus 75 5 Good
lateral surface lower leg
16 F 24 Mex. Lichen simplex chronicus 75 5 Improved
sides of neck17 M 8 C Lichen simplex chronicus 75 6 Good
posterior surface of
neck
18 M 56 C Lichen simplex chronicus 75 6 Good
elbows & outer surface
lower legs
19 M 27 C Lichen simplex chronicus 75 5 Good, recurred
outer surface lt. lower in 4 months
leg & penis 75 4 Good, recurred
in 12 months
20 M 49 C Lichen simplex chronicus 37.5 12 Good
scrotum & sides of nose
21 M 56 C Lichen simplex chronicus 150 15 Improved
inner surface rt. ankle
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TABLE 2—Concluded
CASE SEX AGE COLOR DIAGNOSIS C PER CC. NO.05' RESULTS
22 F 54 C Lichen simplex chronicus Rt. arm & 34 Arms good,
extensor surface both scalp 75 scalp im-
lower arms & back of Lt. arm 37.5 34 proved, re-
neck turned after
9 months
23 F 49 C Lichen simplex chronicus Rt. side 75 16 Good
sides of neck Lt. side 37.5 1624 F 27 C Lichen simplex chronicus 75 9 Poor
inner thighs25 F 12 C Lichen simplex chronicus 75 5 Good
extensor surface each
lower arm
26 F 21 C Lichen simplex chronicus 37.5 10 Good
rt. breast27 F 42 C Lichen simplex chronicus 75 7 Good
rt. wrist, back of neck
28 F 36 C Lichen simplex chronicus 37.5 8 Improved
intragluteal cleft 150 6
29 M 80 W Lichen simplex chronicus 150 17 Improved
outer surface It. lower
leg30 F 24 Japa- Lichen simplex chronicus 8 Good
nese back of neck
31 M 30 W Lichen simplex chronicus 150 Improved
lt. lower arm
32 F 28 W Lichen simplex chronicus 150 11 Good
rt. shin, inner lt. ankle
33 F 37 C Contact dermatitis, dor- 37.5 8 Good
sum of feet. Popliteal
spaces, nylon34 F 51 W Seborrheic dermatitis 75 6 Good
ears, groins & axillae35 F 54 C Lichen sclerosus lt. atro- 150 17 None
phicus, vulva & pubic
area
36 M 73 W Pruritus ani et Scroti 75 7 Good, recurred
4 months
37 F 12 C Toxic dermatitis, Id. 150 14 None38 F 29 C Exudative dermatitis, lt. 15 3 Poor
nipple and areola 37.5 5
75 5
39 M 63 W Psoriasis, lt. knee 150 6 Improved
40 M 39 W Psoriasis, leg, arms, and 75 14 Good
trunk 37.5 14 Good
41 F 44 W Psoriasis, legs and arms See text Good
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These were applied by the same observer (0. H.) with identical technic. Lesions
of lichen simplex chronicus and of psoriasis appeared best suited for this purpose.
A. Lichen Simplex Chronicus. In this group of 23 patients thorium X was
used in strengths varying from 15 to 150 ic per ml. On three patients, cases
10, 22, and 23, two different concentrations were used on similar lesions. Case
,t' 10, a 36 year old negress presented a lichenified, excoriated plaque on each
side and back of neck, with a history of four months duration. The right side
was treated with thorium X(75) while the left side was treated at the same
time with thorium X(15). After 5 applications the skin on the right side was
soft and pliable and the dermatitis had completely involuted while there was
still some pruritus and irritation remaining on the left side. Case 23 had an
eruption very similar to the one above and again thorium X(75) was used on
the right side of the neck and thorium X(37.5) on the left side. Both sides
showed about the same progress leaving soft, nonpruritic and pliable skin after
16 applications of the medication. Case Y 22 presented thickened lichenified
plaques on the extensor surfaces of each forearm and also a similar lesion on
the occiput from which most of the hair had been lost by excoriation and friction.
At the onset of treatment thorium X(75) was used on the right arm and scalp
and the 37.5 c strength was used on the left arm. After eight applications the
arms were showing improvement but the scalp was clinically the same. The
concentration of thorium X was then increased to 150 ic per ml on the scalp
lesion while the strength used on the arms remained the same as at the onset of
treatment. After a total of 34 applications the arm lesions were both soft and
pliable with no pruritus. The scalp, however, never entirely cleared. The derma-
titis on all areas recurred 9 months after the treatments were terminated.
B. Psoriasis. Case 40, a white man 39 years of age, with typical guttate
psoriasis on scattered areas of the body with a history of one year's duration,
was treated with thorium X(15) and (37.5). After 14 applications of each strength
all treated areas had entirely cleared and these particular lesions had not re-
curred at the end of three months observation.
A white woman 44 years of age, case 41, presented a rather extensive
psoriasis of all extremities with many lesions scattered on the trunk. There was
a history of 30 years duration. As this patient was very cooperative different
strengths of medication were used and several biopsies were taken. Five lesions
on the right lower arm were first treated with thorium X(75) and all underwent
involution after 8 applications. Several lightly scaling and thinner lesions over
the outer surface of the right thigh were then treated with thorium X(15) and
these also underwent involution after 8 applications. Some heavily scaled and
infiltrated lesions on the outer surface of the right knee were treated with thorium
X(75) and at the same time similar lesions on the posterior surface of the lower
right leg were treated with 150 c per ml. The first group of lesions entirely
involuted after 24 applications while the latter groups involuted after 21 applica-
tions. Two early lesions on the upper left thigh cleared with five treatments of
thorium X(150). Some of these involuted lesions which were first treated were
followed as long as 2 years without a recurrence of the particular lesion, al-
FIG. 1. Three photomierographs taken at identical magnification
A. Shows an active psoriatic patch from the lower part of the leg of ease 41 before treat-
ment.
B. Shows another portion of the same patch after 14 weekly applications of thorium X
when clinical cure had been achieved.
C. Shows part of the treated area nine months after cessation of treatment. For details
compare text.
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though on other parts of the body some new lesions were appearing from time
to time.
It is our experience that the more infiltrated, thicker, heavily scaled lesions
of psoriasis respond more rapidly to a higher concentration of thorium X than
to one of 15 or 37.5 Mc per ml. However, thin, lightly scaled lesions will also re-
spond to the more dilute solutions.
HISTOLOGIC OBSERVATIONS
In case 41, a biopsy was taken from a typical and rather thick patch of
psoriasis just above the left external malleolus. This patch was then treated
with Thorium X(150). After 17 weekly applications, there was complete involu-
tion with hyperpigmentation. A second biopsy was taken at this time. The lesion
had not recurred nine months later, and the site was clinically normal when a
third biopsy was taken in order to check for possible late effects. Fig. 1 shows
representative areas of the three biopsies at identical magnification. In A the
typical pathologic changes of psoriasis are evident. There is no evidence of
psoriasis in B or C, the epidermis exhibits the normal pattern of arciform rete
ridges which is typical of the lower part of the leg. B shows hyperpigmentation
of the basal layer and peculiar accumulations of "clear cells" (dendritic melano-
cytes) at the tips of the rete ridges.
The same patient volunteered to have biopsies taken after the application of
thorium X to normal skin. Two applications of thorium X(150), (75), (37.5),
FIG. 2. Reproduction of a kodachrome taken of the arm of case 41 one week after the
second application of thorium X to normal skin. Area B was painted with 150 Mc per ml,
area C with 75 /zc per ml, area D with 37.5 Mc per ml, and area E with 15 zc per ml. The
lettering of the areas corresponds to that of the photomicrographs in Fig. 3.
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and (15), respectively, were made to four areas on the outer surface of her arm
at one week intervals. The resulting erythema 1 week after the second applica-
tion is shown in Fig. 2. Five biopsies were then taken, one of each painted area
and one of normal skin. The sections are reproduced in Fig. 3A—E.
A. The normal control area showed the usual configuration of glabrous skin.
The epidermis had a well developed palisade basal layer, 4—5 rows of prickle
cells, one or two rows of granular cells and a relatively thick horny layer. There
was slight variation in size of the nuclei of the stratum spinosum. The basal cells
contained some fine melanin granules, and there was a moderate number of
melanocytes between the palisade cells. Dermal papillae and rete ridges of
moderate length formed a fairly regular pattern. In the corium there was a clear
division between superficial and deep layers with normal vascularity and a few
lymphocytes about or around blood vessels.
B. In the sections of skin which had been treated with thorium X(150) the
FIG. 3. Five photomicrographs taken at identical magnification. Sections stained with
hematoxylin and eosin.
A. Normal skin of outer surface of arm of case 41.
B. Similar area one week after two applications of thorium X, 150 c per ml.
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FIG. 3
C. Similar area after application of thorium X, 75 pc per ml.
D. After thorium X, 37.5 jic per ml.
E. After thorium X, 15 M0 per ml.
For details compare text.
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epidermis was almost twice as thick, but most of the increase was in the horny
layer. The stratum granulosum contained 2—3 rows of cells. The rete mucosum
lacked a palisade layer almost completely and consisted of from two to six rows
of edematous prickle cells. The cells and nuclei varied considerably in size, most
of them being larger than normal. A few mitotic figures were observed. There was
definite increase in the relative number of clear cells and many of them were
dendritic. Pigmentation was increased, pigment granules being present in
dendritic cells as well as in prickle cells up to the keratohyalin layer and even in
some areas of the horny layer. A few isolated cells with pyknotic nuclei and
many melanin granules in the irregular cell body were present in the higher
strata of the rete and there were some dyskeratotic cells. A few polymorpho-
nuclear leukocytes had transmigrated into the epidermis. The pattern of rete
ridges and papillae was irregular and there was a high degree of edema of papil-
lae and subpapillary layer. The blood vessels in these layers were widened, their
endothelia swollen and many were filled with red cells. Edema of the perivascular
tissue was particularly evident and there was a mild perivascular lymphocytic
infiltrate. The deeper layers of the corium and the adnexa were not affected.
C. The changes in the specimen treated with thorium X(75) were similar, but
definitely less severe. The greatest relative increase was in the keratohyalin layer
rather than in the horny layer. The prickle and basal layers were more cellular;
hyperpigmentation and number of dendritic cells were less. The corium was
definitely less edematous and perivascular lymphocytic infiltrate was slightly
more pronounced.
D. There was a great difference between the sections of skin treated with the
higher concentrations and those treated with thorium X(37.5). With low power,
barely any pathologic changes were discernible. More detailed study revealed
some thickening of the stratum granulosurn, spotty irregularity of the basal
layer, some increase of clear cells and dendritic cells, and slightly greater pig-
mentation. There was mild edema, some endothelial swelling and increase of
perivascular lymphocytes in the upper corium.
E. Pathologic changes were minimal in the thorium X(15) specimen.
COMMENT
Thorium X has been used mainly for inflammatory lesions and for nevus
flammeus. Feeny (2f) recommended it for alopecia areata. Recently, Sher and
Howes (3g) have applied it in the treatment of keratoses and superficial epi-
theliomas. It is obvious that neoplastic disease will require high doses for the
destructive effect which is desired. It is questionable, however, if it is necessary
or even desirable to use similarly high doses in the treatment of inflammatory
dermatoses. Some cases of acute damage from local applications of thorium X
were reported in the early years of its use (ig). Late deleterious effects com-
parable to late X-ray and radium sequelae have not, to our knowledge, been re-
ported in recent literature, but it is a general therapeutic rule that the smallest
effective dose is preferable. Moreover, strong concentrations of thorium X pro-
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duce erythema on normal skin, may produce deep and long lasting pigmentation
and may provoke temporarily increased inflammation of the treated lesion.
The purpose of this study therefore was threefold. We wanted to test the ap-
plicability of thorium X therapy in the out-patient clinic of a large city hospital,
to evaluate the clinical effectiveness of low and high concentrations, and to com-
pare the effect of these varied concentrations on the normal skin.
It was believed that the use of a modality of this type in a clientele in which
the course of many dermatoses is prolonged by poor cooperation of the patients
at home might have the advantage of requiring nothing more of the patient
than regular weekly attendance. This usually was obtained, and the savings in
prescriptions and medicaments were probably enough to make the venture
financially feasible even if the thorium X had not been donated for this study.
Although it is generally recommended that scales be removed from the skin as
much as possible before applying thorium X, we decided not to use any other
medication, including keratolytic ointments, in order to avoid the possible
therapeutic effect of such measures. This decision probably had some adverse
influence on our results. Even so, the time needed to clear up notoriously stub-
born diseases such as psoriasis and lichen simplex chronicus compared not un-
favorably with other measures in many cases. The duration of treatment was
lengthened in some cases by the use of very small doses, as low as one-tenth of
the usually recommended concentrations of 150 Mc/ml. Even this small dose
proved effective in suitable cases, but in general 37.5 and 75 jc per ml were
better. In only a few cases was it felt necessary to use a concentration of 150
Mc/ml, and this was in severely lichenified or thickly scaled lesions where the
application of some keratolytic ointment might have been preferable.
It seems necessary to discuss the time factor. Several authors who used high
doses recommended intervals of 2—4 weeks. F. Pinkus (6) however, preferred to
have the patient apply small doses of 15 Me/rnl strength daily for 3 or 4 days. Our
schedule of weekly applications was chosen to fit the hospital routine and may
not have been the most effective one. As far as the effect on normal skin of two
applications at weekly intervals is concerned, there was a striking difference
between the higher and lower concentrations. The break was between the 75
and 37.5 Me/mI strengths. The skin treated with the higher doses showed evi-
dence of rapid exfoliation of the epidermis and edema and mild inflammatory
reaction of the upper corium. Increased exfoliation was indicated by the rela-
tively large proportion of cells in the granular and horny layers and by the
presence of appreciable numbers of mitotic figures. The marked morphologic
alteration of the basal and prickle cells should not be interpreted as "anaplastic"
or possibly "precancerous" inasmuch as similar changes can be found in re-
generating epidermis after simple mechanical stripping of the horny layer (7).
The changes in the corium are consistent with the findings of other observers
that thorium X causes increased lymph flow in the skin. There was an increase
of melanocytic activity, as formerly indicated by Peck (3a). All of these changes
were much less, pronounced when the two lower concentrations were used, just
as clinically a marked reduction of the erythema was obvious. It would appear
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from these findings that drastic alteration of skin metabolism, as it is indicated
in the sites treated with 75 jic/ml and particularly 150 gc/ml strength, is not a
prerequisite for the improvement of many cases of inflammatory dermatoses.
Just as we give divided doses of roentgen rays rather than one erythema dose,
so it is possible to achieve results with thorium X without clinically noticeable
reactions.
5UMMARY
Forty one cases of chronic inflammatory dermatoses, mainly lichen simplex
chronicus and psoriasis, were treated in an out-patient clinic with thorium X.
Results in many cases compared favorably with other types of medication. Some
observations were made on the differential effect of various concentrations of
thorium X on comparable lesions and on normal skin. Concentrations of 37.5
c and 75 gc per ml often seemed to be effective and may be preferable to higher
doses in these inflammatory lesions.
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